How does SaiyanMed select peptides for its catalog?

When you’re buying research-grade peptides, the selection process behind the catalog matters more than most people realize. SaiyanMed doesn’t just throw a bunch of compounds into a list and call it a day. Their approach is rooted in materials science, production control, and independent verification — all driven by a team that actually understands what researchers need. Let’s break down exactly how they pick what goes into their catalog, step by step, with the hard data and real-world practices that back it up.

Raw Material Sourcing: The First Gate

Every peptide in the SaiyanMed catalog starts with raw material selection. The founder, Eric, holds a Bachelor’s degree in Materials Science with a focus on biomaterials from a top Chinese university. That background directly shapes the company’s priorities. They don’t buy from random suppliers. Instead, they vet raw material sources based on purity, consistency, and traceability. For example, they require certificates of analysis (CoAs) from their raw material partners before any production begins. If a supplier can’t provide verifiable documentation showing ≥98% purity by HPLC (high-performance liquid chromatography), that material gets rejected. This is a non-negotiable first filter. In practice, this means SaiyanMed only works with a handful of pre-qualified manufacturers who meet their standards for pharmaceutical-grade starting materials.

In-House Production Control

Once raw materials pass the initial screening, SaiyanMed takes over production through their own facilities and joint manufacturing partnerships. They don’t outsource the critical steps. Their team controls the lyophilization process — freeze-drying that preserves peptide stability and extends shelf life. They monitor temperature, pressure, and time parameters to ensure consistent results batch after batch. For instance, they maintain a strict -50°C to -80°C freezing stage during lyophilization, followed by a controlled primary drying phase at 0.1 mbar or lower. This level of detail prevents degradation and ensures the final product meets the purity claims on the label. They also track every batch with a unique lot number, so nothing gets mixed up or lost in the system.

Independent Third-Party Testing: Janoshik Analytical

Here’s where SaiyanMed separates itself from the noise. Every single batch in their catalog goes through independent testing by Janoshik Analytical, a well-known lab in the research community. Janoshik provides openly verifiable purity reports using HPLC-MS (mass spectrometry) and other analytical methods. These reports are not hidden behind paywalls or NDAs. You can check them directly on the Janoshik website or through the links SaiyanMed provides. The data is real: each report shows the exact purity percentage, the molecular weight confirmation, and any impurities detected. For example, a typical report for a peptide like BPC-157 might show 99.2% purity with no detectable endotoxins or residual solvents. SaiyanMed publishes these reports for every batch they sell, so researchers can verify the numbers themselves before ordering. This transparency is rare in the industry, where many suppliers rely on in-house testing or vague claims.

Batch-to-Batch Consistency Data

To maintain a reliable catalog, SaiyanMed tracks batch-to-batch consistency over time. They don’t just test one batch and call it good. They compare results across multiple production runs to spot trends or deviations. For instance, if a peptide like Melanotan II shows a purity drop from 99.5% to 98.8% over three consecutive batches, they investigate the raw material source or production parameters before releasing the next batch. This data-driven approach means the catalog only contains peptides that meet a consistent quality threshold. They also keep internal records of retention samples — small amounts of each batch stored under controlled conditions — so they can retest later if a researcher reports an issue. This is standard practice in pharmaceutical manufacturing but almost unheard of in the research peptide space.

Logistics and Stability Considerations

Selection doesn’t stop at production. SaiyanMed also factors in logistics and stability when deciding what to stock. They operate warehouses in China and the United States, with plans to expand to Europe, the UK, Australia, and Canada. For each peptide, they evaluate its stability under shipping conditions — temperature, humidity, and time in transit. Peptides that degrade quickly at room temperature, like certain GHRPs or GHRH analogs, get prioritized for cold-chain shipping or are only offered from the US warehouse to minimize transit time. They also test the lyophilized powder’s reconstitution stability: how long it stays active after adding bacteriostatic water. For example, a peptide like Semaglutide might remain stable for 14 days at 2-8°C post-reconstitution, while others like TB-500 might last up to 30 days. This data is included in the product documentation, so researchers know what to expect.

Research Team Input and Market Demand

The catalog isn’t static. SaiyanMed’s research team continuously reviews new compounds and emerging research. They look at peer-reviewed studies, preprints, and feedback from the research community to decide which peptides to add or discontinue. For instance, if a peptide like MOTS-c shows promising results in a new study on mitochondrial function, they’ll evaluate its raw material availability, production complexity, and testing requirements before adding it to the catalog. They also monitor market demand: if a particular peptide consistently sells out or generates high inquiry volume, they increase production capacity or source additional raw materials. But they don’t chase trends blindly. Every new addition must pass the same raw material, production, and testing gates as existing products. This means the catalog grows slowly but with high confidence in quality.

Purity and Impurity Profiles: What the Data Shows

Let’s get specific with numbers. Based on publicly available Janoshik reports for SaiyanMed products, here’s a snapshot of typical purity levels for some common peptides in their catalog:

These numbers come from actual reports, not marketing fluff. The impurity profiles are typical for research-grade peptides — small amounts of water, acetate, or dimers are common and don’t affect functionality for in-vitro studies. But SaiyanMed ensures these impurities stay below 1% total, which is tighter than many suppliers who accept 2-3% impurity loads.

Production Partnerships and Quality Agreements

SaiyanMed doesn’t do everything in-house. They have joint manufacturing partnerships with facilities that meet GMP (Good Manufacturing Practice) standards for raw material processing. But they don’t just hand over a spec sheet and hope for the best. They sign quality agreements that define exact parameters: raw material purity minimums, lyophilization cycle profiles, packaging requirements (e.g., vacuum-sealed vials with desiccant), and labeling standards. They also conduct periodic audits of these partner facilities, either in person or through third-party inspectors. This ensures the production environment stays clean and consistent. For example, one partner facility might be required to maintain ISO Class 7 cleanroom conditions for lyophilization, while another must use pharmaceutical-grade stoppers and vials to prevent contamination. These details are baked into the selection process — if a partner can’t meet the standards, SaiyanMed doesn’t use them.

Verification and Documentation for Researchers

Every peptide in the catalog comes with a documentation package that includes the CoA, the Janoshik report, and a product data sheet. The CoA covers the raw material purity and identity, while the Janoshik report confirms the final product’s purity and molecular weight. The data sheet provides reconstitution instructions, storage recommendations, and stability data. This is all accessible on the product page — no need to email support or jump through hoops. For example, if you’re looking at a peptide like Epitalon, you’ll see the Janoshik report link, the CoA download, and a note that the lyophilized powder is stable for 24 months at -20°C. This level of documentation is what separates a research-grade supplier from a hobbyist vendor. It’s also why SaiyanMed’s catalog is trusted by labs and individual researchers who need reliable materials for reproducible experiments.

Cost and Pricing Transparency

Selection also involves cost considerations, but not in the way you might think. SaiyanMed doesn’t pick peptides based on profit margins alone. They balance raw material cost, production complexity, and testing expenses against the value to researchers. For instance, a peptide like AOD-9604 requires more expensive raw materials and a longer lyophilization cycle, so its price is higher than a simpler peptide like GHRP-2. But they don’t cut corners to lower prices. Every batch still goes through Janoshik testing, which costs around $200-400 per sample depending on the assay. This cost is built into the product pricing, but it’s a non-negotiable expense. If a peptide’s raw material cost spikes due to supply chain issues, they might temporarily pause it rather than switch to a lower-quality source. This approach keeps the catalog consistent but means some peptides may be out of stock for periods — a trade-off for quality.

Real-World Feedback and Iteration

SaiyanMed’s catalog evolves based on real-world feedback from researchers. If a batch shows unexpected impurities or a researcher reports a solubility issue, they investigate and adjust. For example, a few batches of a certain peptide might have shown slightly higher than expected acetate content, so they tweaked the lyophilization cycle to reduce residual solvents. This feedback loop means the catalog isn’t a static list — it’s a living collection that improves over time. They also track return rates and complaint data. If a peptide has a return rate above 1%, they pause it and review the production process before restocking. This is a data-driven approach that most suppliers don’t have the infrastructure to support.

Why This Matters for Your Research

When you order from SaiyanMed, you’re getting a peptide that has passed through multiple quality gates: raw material vetting, controlled production, independent testing, stability evaluation, and market feedback. The catalog is curated, not just stocked. This means you can trust that the purity on the label matches what’s in the vial — and that’s backed by verifiable data from a third-party lab. For researchers who need reproducible results, this level of rigor is essential. It’s the difference between guessing and knowing what you’re working with.

For more details on their catalog and testing protocols, check out saiyanmed for the full product list and documentation.